AKRO - Akero Therapeutics, Inc.
54.65
0.100 0.183%
Share volume: 15,312,254
Last Updated: 12-08-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$54.55
0.10
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | 02-28-2025 | 05-12-2025 | 08-08-2025 | 11-07-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 59.954 M | 65.741 M | 81.703 M | 78.025 M | 80.882 M | 80.873 M | 90.236 M | |
| Selling general and admin | 9.304 M | 10.419 M | 9.471 M | 8.732 M | 11.315 M | 11.619 M | 11.353 M | |
| Research and development | 50.650 M | 55.322 M | 72.232 M | 69.293 M | 69.567 M | 69.254 M | 78.883 M | |
| Total expenses | 59.954 M | 65.741 M | 81.703 M | 78.025 M | 80.882 M | 80.873 M | 90.236 M | |
| 9.65% | 24.28% | -4.50% | 3.66% | -0.01% | 11.58% | |||
| Operating income | -59.954 M | -65.741 M | -81.703 M | -78.025 M | -80.882 M | -80.873 M | -90.236 M | |
| Ebit | -59.954 M | -65.741 M | -81.703 M | -78.025 M | -80.882 M | -80.873 M | -90.236 M | |
| Pretax income | -53.344 M | -55.987 M | -72.705 M | -70.024 M | -70.725 M | -70.505 M | -81.566 M | |
| 4.95% | 29.86% | -3.69% | 1.00% | -0.31% | 15.69% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -53.344 M | -55.987 M | -72.705 M | -70.024 M | -70.725 M | -70.505 M | -81.566 M | |
| -4.95% | -29.86% | 3.69% | -1.00% | 0.31% | -15.69% |